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ABSTRACT Intracellular regulation of oocyte
meiosis is not completely understood. However,
reversible phosphorylation, which involves serine/
threonine protein kinases and phosphatases (PP), is
an important mediator. Glycogen synthase kinase-3
(GSK-3) is a highly conserved serine/threonine protein
kinase. Currently no reports exist on presence or func-
tion of GSK-3 in mammalian oocytes. The aim of this
study was to determine GSK-3 presence/absence,
transcript and protein expression, intracellular protein
distribution, and to investigate the functional impor-
tance of GSK-3 in mouse oocyte meiosis. Germinal
vesicle-intact (GVI) oocytes contained both GSK-3
transcript and protein. Although GSK-3 b-isoform is
the only transcript identifiable in GVI oocytes, both
a- and b-isoforms were recognized by Western blot
analysis. In growing, meiotic-incompetent oocytes
GSK-3 was present, diffusely located throughout
the cytoplasm and absent in the nucleus, whereas in
meiotic-competent oocytes this cytoplasmic GSK-3
displays a predominant peri-oolemma staining. Treat-
ment of mouse GVI oocytes with lithium chloride (LiCl),
which inhibits both inositol monophosphatase (IM-
Pase) and GSK-3, had no significant influence on
oocyte viability, morphology, or development to meta-
phase II (MII). However, LiCl caused abnormal spindle
formation and significantly increased incidence of
abnormal homologue segregation during the first meio-
tic division. L690,330, which is a specific IMPase
inhibitor, had no significant effect on oocyte viability,
morphology, MII development, or homologue segrega-
tion. This is the first report of GSK-3 in mammalian
oocytes. LiCl inhibition of mouse oocyte GSK-3
modified organization of microtubules and/or function
of meiotic spindles thus compromising segregation of
condensed bivalent chromosomes. Mol. Reprod. Dev.
64: 96–105, 2003.  2003 Wiley-Liss, Inc.
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INTRODUCTION
Important events occurring during oocyte meiotic
maturation are germinal vesicle breakdown (GVBD),
condensation of chromatin, alignment of bivalents on
spindles at metaphase I (MI), and separation and se-
gregation ofhomologues during anaphaseand telophase
I. This nuclear maturation process is considered com-
plete following bivalent chromatin separation in con-
junction with disproportionate cytokinesis, extrusion of
the first polar body and meiotic arrest at metaphase II
(MII). While the importance of kinases and phospha-
tases, and thus reversible phosphorylation, in regula-
tion of meiosis is well appreciated the actual enzymes
and their intracellular roles in controlling meiotic pro-
gression are incompletely understood.
Lithium chloride (LiCl) has been used to study intra-
cellular regulation of mouse oocyte meiosis with contra-
dictory outcomes. Initially LiCl was shown to stimulate
GVBD in oocytes treated with the meiotic-blocking
agent forskolin, but not in the presence of dibutyryl-
cAMP (dbcAMP; Gavin and Schorderet-Slatkine, 1988).
Conversely, LiClwas found to stimulate bothGVBDand
polar body formation in the presence of dbcAMP (Bagger
et al., 1993). Pesty et al. (1994) reported that LiCl inhi-
bits both GVBD andMII development in spontaneously
maturedoocytes.Lastly,LiClwas found tohavenoeffect
on oocyte spontaneous, but inhibited hormonal- and
growth factor-stimulated, resumption of meiosis (Cotic-
chio and Fleming, 1998). There are two primary mecha-
nismsofaction toaccount forLiCl’s cellulareffects.First,
LiCl can inhibit inositol monophosphatase (IMPase),
which results in depletion of endogenous inositol thus
preventing formation of inositol triphosphate (IP3; Hall-
cher and Sherman, 1980; Berridge et al., 1989). Second,
LiCl can inhibit both isoforms of glycogen synthase
kinase-3 (GSK-3) (Klein and Melton, 1996; Stambolic
et al., 1996). Past studies on LiCl’s effects on oocytemat-
uration have focused on the role of polyphosphoinositide
metabolismwithoutconsiderationof theGSK-3pathway.
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GSK-3 is a highly conserved serine/threonine protein
kinase that was initially discovered as one of many
kinases that phosphorylate and inactivate glycogen
synthase, the rate-limiting enzyme in glycogen synth-
esis (Embi et al., 1980; Rylatt et al., 1980; Hemmings
et al., 1982). GSK-3 is active in resting cells and is pri-
marily regulated by inactivation in response to signal
transduction pathways originating from various growth
factors (Cook et al., 1996). Molecular cloning revealed
existence of two highly related proteins termed GSK-3a
and GSK-3b with molecular masses of 51 and 46 kDa,
respectively (Woodgett, 1990; Hughes et al., 1992).
WhileGSK-3 function has beenwell studied in neuronal
(review see: Phiel and Klein, 2001) and somatic cells
(review see: Sakanaka et al., 2000) its presence and/or
role in mammalian gametes is limited to studies in
spermatozoa (Smith et al., 1996; Smith et al., 1999;
Vijayaraghavan et al., 2000).
GSK-3 is involved in awide range of cellular processes
beyond regulation of glycogen synthases. For instance,
GSK-3 phosphorylates the inhibitory subunit I2 of
the protein phosphatase-1 (PP1)–I2 complex thus activ-
ating PP1 (VandenHeede et al., 1980; Hemmings
et al., 1981). GSK-3 can interrupt the Wnt/b-catenin
transduction pathway by destabilizing b-catenin and
thus blocking b-catenin-induced transcription (Saka-
naka et al., 2000), as well as regulate transcription
through transcription factors such as c-jun, c-myc, and
CREB (Boyle et al., 1991; Plyte et al., 1992; Fiol et al.,
1994). In addition, GSK-3 can regulate phosphorylation
of numerous microtubule associated proteins subse-
quently influencing microtubule polymerization and
stability, spindle formation, and function (Stambolic
et al., 1996; Moreno and Avila, 1998; Lovestone et al.,
1999; Sanchez et al., 1999). Interestingly, it has been
reported that LiCl treatment of mouse oocytes causes
important changes in meiotic spindle configuration
and function, as well as chromatin organization (Pesty
et al., 1994). However, it has not been determined
whether this LiCl effect is through inhibition of IMPase
or GSK-3.
The objective of the first portion of this study was
to determine GSK-3 presence/absence within mouse
oocytes, characterize GSK-3 transcript and protein
expression, and elucidate the intracellularGSK-3distri-
bution during oocyte growth and acquisition of meiotic
competence. Secondly, experiments were performed to
evaluate influences of the GSK-3/IMPase inhibitor,
LiCl, and the specific IMPase inhibitor, L690,330 (Atack
et al., 1993; Klein and Melton, 1996), on mouse oocyte
viability, spontaneousmeiotic resumption, and progres-
sion, microtubule polymerization and spindle forma-
tion, and homologue segregation.
MATERIALS AND METHODS
Collection of Ovarian Tissue, Oocytes,
and Oocyte Culture
Ovaries were obtained fromCF-1mice on day 11 or 15
(day 0¼day of birth) without hormonal stimulation or
from 19- to 23-day-old mice primed with 10 IU equine
chorionic gonadotropin (eCG, Sigma Chemical Co.,
Louis, MO). Fully-grown GVBD-competent oocytes
were isolated by manual rupturing of antral ovarian
follicles. Oocytes were isolated into modified Human
Tubal Fluid mediaþ0.3% (wt/vol) polyvinylpyrrolidone
(HTFHþPVP; Quinn et al., 1985; Irvine Scientific,
Santa Ana, CA) for transcript and protein studies
or HTFHþ0.3% (wt/vol) bovine serum albumin (BSA,
Fisher Scientific, Fair Lawn, NJ) for culture experi-
ments. For reverse transcription-polymerase chain
reaction (RT-PCR) and Western blot analysis germinal
vesicle-intact (GVI) oocytes were completely freed of
attached cumulus cells in HTFHþPVP by manual
pipetting with a hand-pulled borosilicate pipette.
Cumulus-free fully-grown GVI oocytes were frozen in
liquid nitrogen and stored at 808C until RNA and
protein extracts were prepared. For immunohistochem-
ical studies, ovaries were fixed in 4% (wt/vol) parafor-
maldehyde (prepared fresh daily), rinsed in PBS, and
embedded in paraffin.
For culture experiments, GVBD-competent oocytes
and accompanying cumulus cells were placed in HTF
containing 0.3% BSA alone or containing potassium
chloride (KCl), LiCl, or L690,330 (Tocris, Ballwin, MO).
Following 16 hr incubation at 378C with 5% CO2 in air,
cumulus cells were removed by manual pipetting and
viability, morphology, and stage of meiotic development
were assessed with an inverted microscope using Hoff-
man optics at 400. In some experiments, resultingMII
oocytes were used for immunocytochemical analysis for
normal microtubule polymerization/spindle formation.
In addition, MII oocytes in vitro-matured in HTF alone
(control; n¼56), or containing 20 mM KCL (n¼ 65),
20mMLiCl (n¼79), 20mML690,330 (n¼ 60)were stain-
ed with 5 mg/ml Hoechst 3342, mounted by 90% (vol/vol)
glycerol in PBS, and chromatinwas visualizedwith con-
ventional fluorescence microscopy at 1,000. Oocytes
were evaluated, in a treatment-blinded fashion, for
normal homologue segregation. Effect of treatment on
percentage of MII oocytes with abnormal homologue
segregation was statistically analyzed with Fisher’s
Exact Test. Differences were considered significant
with P<0.05.
Oocyte RNA Isolation and RT-PCR
Eighty to one hundred oocyteswere thawed in 20.0 IU
RNasin (Promega, Madison, WI), pooled and lysed with
5 freeze/thaw cycles in liquid nitrogen. Total RNA was
isolated as previously described (Heikinheimo et al.,
1995; Smith et al., 1998). Complementary DNA was
synthesized using the ‘‘Superscript Preamplification
System for First Strand cDNA Synthesis’’ reagents and
methodology (Gibco BRL, Gaithersburg, MD). Oligo-dT
was used to prime reverse transcription reactions. In
the case ofGSK-3a, both oligo-dT and a gene specific pri-
mer (GSP) were used.
For GSK-3a and GSK-3b PCR sense and antisense
primers were designed from areas with least homo-
logy to amplify size-discernible products with distinct
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restriction endonuclease digestion sites (Table 1). Each
PCR was performed with five oocyte equivalents of
cDNA, 20 pmoles of each primer, and PCR cocktail
[0.4 mM of each dNTP, 2.0 mM MgCl2, 10.0 mM Tris-
HCl (pH 8.3), 50.0 mM KCl, and 2.0 I.U. of Taq DNA
polymerase (Perkin-Elmer, Foster City, CA)]. In addi-
tion, control reactions were conducted consisting of (1)
no template with primers and cocktail; (2) no primers
with cDNA template and cocktail; (3) no template or
primer with cocktail, and (4) total RNA as template
(equivalent to five oocytes) with primers and cocktail.
Total RNA controls were only performed if amplification
signals were previously identified in oocytes. Polymer-
ase chain reactions entailed 1 cycle for 2 min at 948C;
35 cycles of 948C for 1 min, 558C (GSK-3a and GSK-3b)
for 1 min, 728C for 1 min; and 1 cycle at 728C for 2 min.
Polymerase chain reaction products were separated
on 2.0% (wt/vol) low melting agarose gels (Sigma) and
isolated as previously described (Smith et al., 1998).
Portions of the amplified products were digested for 2 hr
with DraI (GSK-3a) or BstXI (GSK-3b). Undigested
and digested PCR products, as well as PCR controls,
were separated using 8% (wt/vol) polyacrylamide gel
electrophoresis and visualized with ethidium bromide
staining. Reverse transcription-PCR experiments were
performed in triplicate with each primer set to ensure
repeatability of results. In addition, purified PCR
products were sequenced by cycle sequencing (ABI
Prism, Perkin-Elmer) followed with product analysis
using an Applied BiosystemsModel 373A DNA Sequen-
cer. Sequences obtained were compared with existing
sequences in GenBank with the use of ‘‘BLAST’’ via the
internet.
Electrophoresis and Western Blot Analysis
Fully grownGVI oocytes were cultured in HTFmedia
containing 0.3% BSA for 2 hr. Oocytes that had under-
gone GVBD were selected and incubated for an
additional 5 and 16 hr for progression to MI and MII.
Two hundred frozen cumulus cell-free, fully-grownGVI,
MI, and MII oocytes were thawed in 2 SDS–PAGE
sample buffer [80mMTris-HCl (pH¼ 6.8), 20% (vol/vol)
glycerol, 4% (wt/vol) SDS, 4% (vol/vol) 2-b-mercap-
toethanol, and 0.04% (wt/vol) bromophenol blue], vor-
texed and placed on ice for 15 min. Following sonication
on ice for 10 sec, samples were denatured at 908C for
10 min and cooled on ice for 5 min. Samples were stored
at 208C until electrophoresis was performed.
Fivemicrogramsofmousebrainand twohundredmouse
oocytes total protein were added per lane and separated
by one-dimensional SDS–PAGE (Laemmli, 1970). Gels
were equilibrated in TBST [25 mM Tris-HCl (pH 7.8),
125 mM NaCl, 0.1% (vol/vol) Tween] and proteins
transferred to Hybond-P PVDF membrane using a
Semi-Dry Electrophoretic Transfer Cell (Bio-Rad
Laboratories, Hercules, CA) according to the manu-
facturer’s instructions. Blotswere blocked in 5% (wt/vol)
nonfat milk in TBST at room temperature (RT) for 1 hr.
Then, blots were incubated with anti-GSK-3 (diluted
1:1000, recognizes both a and b isoforms, Upstate
Biotechnology, Lake Placid, NY) antibody in TBST plus
5% nonfat milk at 48C overnight with gentle agitation.
After completely washing, Blots were, incubated for
60 min at RT with agitation in an anti-rabbit horse-
radish peroxidase-conjugated IgG (diluted 1:10,000),
washed three times in TBST and developed with ECL
Plus reagents (Amersham Life Sciences, Buckingham-
shire, UK) per manufacturer’s instructions.
Immunohistochemistry (IHC)
Fixed, paraffin-embedded ovaries were sectioned at
5 mm intervals, placed on superfrost-plus slides (Fisher
Scientific, Itasca, IL), deparaffinized, placed in 100 mM
glycine buffer (pH 3.65) and microwaved for 10 min
for antigen retrieval (Shi et al., 1995). To reduce
background signal, sampleswere placed inTris buffered
saline (TBS; 50 mM Tris pH 7.6, 150 mM NaCl)
containing 5.0% (vol/vol) dimethyl sulfoxide and 0.2%
(vol/vol) Tween-20 for 10 min, rinsed in TBS and
incubated for 10 min in TBS containing 0.3% (wt/vol)
BSA, 1 mg/ml sodium azide, and 1.6% (vol/vol) normal
goat serum (Vector Laboratories). In addition, endogen-
ous avidin and biotin were neutralized with an avidin/
biotin blocking kit (Vector Laboratories). Slides were
rinsed and incubated overnight with anti-GSK-3
(diluted 1:500) antibody at RT in a humidified chamber;
slides were then rinsed, washed [TBS þ0.05% (vol/vol)
Tween-20], rinsed again and incubated with the bioti-
nylated secondary antibody for 30 min at RT. After
secondary antibody exposure, slides were quenched in
3.0% (vol/vol) H2O2 in 90% (vol/vol)methanol for 30min,
then rinsed and incubated for 30 min in avidin–biotin
conjugated to peroxidase (Vector Laboratories). After
several rinses, sections were exposed to 0.025% (wt/vol)
3,30-diaminobenzidine (DAB, Dojindo Labs-Wako
Chemical, Richmond, VA), rinsed, counterstained with
TABLE 1. Primers Utilized for Polymerase Chain Reactions for Glycogen Synthase Kinase-3 (GSK-3) in
Mouse Oocytes




enzyme digest products (bp)
GSK-3a 50 CTCACTAACTCTTCCTGAGG 30 417 235þ 182 (DraI)
50 GGATGGTGTGAATCGACG 30
GSK-3b 50 GGTGAATCGAGAAGAGCCAT 30 259 118þ 141 (BstXI)
50 CTCCTGAGTCACAAAGTTTG 30
aSequence derivation, GSK-3a and b (ref. NM 017344.1) in Genbank.
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Mayer’s hematoxylin (Sigma), dehydrated by three
changes of ethanol, then three changes of xylene and
mounted. Positive controls consisted of mouse heart.
Negative controls included (1) elimination of the
primary antibody (not shown) and (2) nonimmune
rabbit serum (NIRS) in place of the primary antibody.
Immunocytochemistry and Confocal
Microscope Analysis
In order to identify the effect of LiCl on microtubule
assembly during oocyte maturation, in vitro-matured
MII oocytes were collected and fixed in 2% (wt/vol)
paraformaldehyde with 0.04% (vol/vol) Triton X-100.
Oocytes were then blocked overnight with 0.3% (wt/vol)
BSA in PBS at 48C, and incubated with a monoclonal
anti-b tubulin antibody at a 1:200 dilution for 1 hr at
378C. After washing with 0.3% BSA plus 0.1% (vol/vol)
Tween-20 in PBS, oocytes were incubated in the same
wash buffer for 90 min at 378C. Samples were then
reacted with anti-mouse Alexa 488-conjugated second-
ary antibody (Molecular Probes, Eugene, OR) at a
1:1,000 dilution for 1 hr at 378C. Following washing,
slideswere incubatedwith 5 mg/ml propidium iodide (PI)
in PBS containing 0.1% (wt/vol) BSA for 20min at 378C.
Slides were then mounted with 90% glycerol in PBS for
fluorescence microscopic visualization with a Bio-Rad
MRC-600 confocal scanning laser microscope.
RESULTS
GSK-3 Transcript in Mouse Oocytes
GSK-3 presence has never been reported in mamma-
lian oocytes, therefore, we approached identification
and characterization at the transcript and protein
levels. Primers specific for rat brain GSK-3a amplified
an 417 bp product from mouse brain cDNA produced
by reverse transcription with either oligo-dT or gene-
specific primers (GSP; Fig. 1, lanes H and J). Amplified
products from mouse brain contained the anticipated
DraI digest sites that upon cleavage resulted in 235
and 182 bp products (Fig. 1, lanes G and I). No ampli-
fication signals were detected in contamination control
reactions (Fig. 1, lanes B–D). Complementary DNAs
were produced by reverse transcription of fully-grown
mouseoocyteRNAprimedwith oligo-dTandGSP.These
two reverse transcriptionapproacheswereusedbecause
of GSK-3a protein identification (discussed in following
section) and concern that GSK-3a transcript identifica-
tion might be missed due to de-polyadenylation of
transcript. However, PCR with primers for GSK-3a,
using either oligo-dT or GSP-primed cDNA from fully-
grown oocytes, showed no amplification product (Fig. 1,
lanes E and F) indicating a lack of intact GSK-3a
transcript in fully-grown oocytes. Mouse oocyte cDNA
produced by RT-PCR with primers specific for GSK-3b
yielded approximately a 259 bp product (Fig. 2A, lane F)
that contained the anticipatedBstXI digest site (Fig. 2A,
lane G). Control PCR reactions displayed no reagent
contamination. The sequence of this product showed
97% similarity to rat brain GSK-3b (Fig. 2B).
Fig. 1. Absence of glycogen synthase kinase-3a (GSK-3a) mRNA
inmouse oocytes. Polyacrylamide gel electrophoresis of PCR-amplified
products of fully-grown GVI oocyte and brain cDNAs using primers
designed from rat brain GSK-3a sequence. Lanes A and K, PCR
markers; lane B, no cDNA, no primers; lane C, cDNA, no primers;
laneD, primers, no cDNA; laneE,mouse oocyte cDNAproduced using
gene specific primers (GSP) for reverse transcriptionplusPCRprimers;
lane F, mouse oocyte cDNA produced using oligo-dT primers (dT) for
reverse transcription plus PCR primers; lane G, mouse brain cDNA
produced using GSP for reverse transcription plus PCR primers
followed by DraI digest; lane H, mouse brain cDNA produced using
GSP for reverse transcription plus PCR primers; lane I, mouse brain
cDNA produced using dT for reverse transcription plus PCR primers
followed by DraI digest; lane J, mouse brain cDNA produced using
dT for reverse transcription plus PCR primers.
Fig. 2. Identification of mouse oocyte GSK-3b mRNA by RT-PCR/
polyacrylamide gel electrophoresis and cDNA sequencing. A: PAGE of
PCR-amplified products of fully-grown GVI oocytes cDNA using
primers designed from rat brain GSK-3b. Lanes A and H, PCR
markers; lane B, no cDNA, no primers; lane C, cDNA, no primers;
lane D, primers, no cDNA; lane E, mouse oocyte total RNA and
primers; lane F, mouse oocyte cDNA and primers; lane G, mouse
oocyte cDNA and primers followed by BstXI digest. B: Sequence of
mouse oocyte GSK-3b PCR-amplified product, which showed 97%
similarity to rat brain GSK-3b. Underlined nucleotides are dissimilar
to rat brain GSK-3b.
GSK-3 AND MOUSE OOCYTE MEIOSIS 99
GSK-3 Protein in Mouse Oocytes
To further confirm the presence of GSK-3 in mouse
oocytes, Western blot analyses were performed on
isolated denuded fully-grown oocytes. Both a and b
isoforms of GSK-3 were identified at 51 and 46 kDa,
respectively, within the positive control tissue, mouse
brain, andmouse oocytes (Fig. 3). To further investigate
the presence and intra-oocyte location of GSK-3, im-
munohistochemistry experiments were performed on
ovarian tissue removed from pre-pubertal (11- and
15-days-old) and PMSG-stimulated adult mice. For
nonspecific signal controls, GSK-3 antibody was replac-
ed with nonimmune rabbit serum (NIRS). These con-
trols displayed negligible staining inmouse prepubertal
and PMSG-stimulated adult (not shown) ovaries, as
well as heart (Fig. 4). In addition, mouse heart was used
as positive control tissue and showed intense, diffuse
cytoplasmic staining of themyofibril cytoplasm.Ovaries
of prepubertalmice 11 and 15days of age predominantly
contain static and growing oocytes within primordial,
primary and secondary follicles (Fig. 4). These oocytes
containGSK-3,whichdisplays diffuse staining through-
out the cytoplasm and a marked absence within the
nucleus. Fully-grown oocytes in late preantral and
antral follicles from PMSG-stimulated adult ovaries
show diffuse cytoplasmic staining of GSK-3, absence in
the nucleus and a concentration in close proximity to
the oolemma.
GSK-3 and Oocyte Meiosis
In order to investigate the functional importance of
GSK-3 in mammalian oocytes we utilized the IMPase/
GSK-3 inhibitor, LiCl. CulturingGVI oocytes in increas-
ing doses of LiCl for 16 hr had no significant effect on
oocyte viability, as assessed by degeneration, GVBD, or
MII development in comparison to no-treatment or
KCl controls (Table 2). At the light microscope level,
morphological appearance of in vitro-matured oocytes
treated with 20 mM LiCl was similar to control and
20 mMKCl treatments. However, MII oocytes matured
in the presence of 20 mM LiCl had reduced micro-
tubule polymerization, abnormalMII spindle formation
and aberrant homologue segregation (Fig. 5). Because
lithium can inhibit bothGSK-3 and IMPase,weused the
specific IMPase inhibitor-L690,330 (Atack et al., 1993;
Klein and Melton, 1996) in a similar experimental
protocol to determine if this influence of LiCl on homo-
logue segregation was due to inhibition of GSK-3 or
IMPase. Oocyte viability (not shown), GVBD, MII de-
velopment, and oocyte activation (Table 3) were not
significantly different between treatments. In addition,
morphological appearance of oocytes, as visualized with
lightmicroscopy,wasnormal and similar between treat-
ments (data not shown). All MII oocytes in each
treatment group were assessed for normal (Fig. 6A) or
abnormal (Fig. 6B–F) homologue segregation. MII
oocytes cultured in LiCl had significantly higher in-
cidence of abnormal homologue segregation (39.8%;
P< 0.01) compared to control media (4.2%), KCl
(4.6%), and L690,330 (5.9%) treatments (Fig. 7).
DISCUSSION
GSK-3 was first identified as the kinase that phos-
phorylates and inactivates glycogen synthase, which is
the rate-limiting enzyme in glycogen synthesis (Embi
et al., 1980; Rylatt et al., 1980; Hemmings et al., 1982).
Subsequently GSK-3 was found to be identical to factor
A (FA) that was known to activate PP1 through phos-
phorylation of I2 (Vandenheede et al., 1980). Molecular
cloning revealed the existence of two highly-related
proteins termed GSK-3a and GSK-3b with molecular
masses of 51 and 46 kDa, respectively (Hughes et al.,
1992). We have addressed the identification of mouse
oocyte GSK-3 from both transcript and protein levels.
Initially, using RT-PCR with oligo-dT-primed reverse
transcription we identified GSK-3b, but not GSK-3a,
transcripts in fully-grown mouse oocytes. These experi-
ments were followed by repeated Western blot analyses
of fully-grown mouse oocyte proteins with an antibody
that recognizes both a and b forms of GSK-3. A 51-kDa
protein was recognized, corresponding to GSK-3a, in
addition to the 46-kDa protein corresponding to GSK-b.
Because de-polyadenylation of transcripts has been
reported previously in the oocyte (Bachvarova and
Paynton, 1988), we speculated that we might have
missed the GSK-3a transcript with the use of oligo-dT
primed reverse transcription. These experiments were
repeated with gene-specific primers for reverse tran-
scription. Even though this scenario resulted in ampli-
fication of GSK-3a in control tissue we were unable to
amplify a product from oocytes. In addition, mRNA
within the oocyte samples was present, and intact, as
supported by the ability to serve as a template for GSK-
b. Thus,wehave concluded thatwithin themouse oocyte
GSK-3a is transcribed, translated, and its mRNA is
subsequently degraded,whereasGSK-3b is transcribed,
translated, and its transcript remains stable. This
raises the question of importance of oocyte-derived
GSK-3b transcript in early embryogenesis. Conversely,
it stimulates the questioning of if/when GSK-3a gene
Fig. 3. Immunoblot analysis of GSK-3a and b in fully-grown GVI,
MI, and MII mouse oocytes. Approximately 5 mg of mouse brain
(positive controls for GSK-3a and b), or 200-cumulus cell-free oocyte
total protein were loaded per lane. The polyclonal antibody used
recognized both GSK-3a and b at 51 and 46 kDa, respectively, in
positive control tissues. Mouse oocytes contained GSK-3a andGSK-3b.
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expression is turned-on during preimplantation embryo
development. Both of these questions need to be ad-
dressed in the future.
We also asked the question where, within the oocyte,
is GSK-3 located with respect to developmental compe-
tence. The diffuse cytoplasmic staining of GSK-3 in
oocytes of all sizes and contained in all stages of follicles
present on days 11 and 15 is quite different from the
Fig. 4. Representative immunohistochemical localization of GSK-3
in mouse oocytes during prepubertal ovarian development around the
time of age-related acquisition of meiotic competence and following
adult PMSG-stimulation. Nonimmune rabbit serum (NIRS) replacing
the primary antibody showed negligible background staining in mouse
ovaries and heart. Polyclonal antibodies, which recognizes both GSK-
3a and b, displayed reactivity in the cytoplasm of mouse myofibrils
(positive control tissue). Oocyte GSK-3was detectable in the cytoplasm
at 11 and 15 days of age, when the majority of oocytes are GVB-
incompetent and beginning to acquire meiotic competence, respecti-
vely. In adult PMSG-stimulated ovaries cytoplasmic GSK-3 is present
with a pronounced intensity in close proximity to the oolemma.
Fig. 5. Representative immunocytochemical identification ofmicro-
tubule polymerization, spindle formation, and chromation localization
inMII oocytes matured in KCl (a; insert) or LiCl (A–D). Green and red
fluorescence indicates b-tubulin and chromatin staining, respectively.
All MII oocytes, independent of treatment, were processed at the same
time, under identical conditions, and assessed with scanning laser
microscopy. Oocytes matured in KCl (a, insert) and LiCl (A, B) were
visualized under identical fluorescent intensities. The same MII
oocytes mature in LiCl (A, B) were further assessed with increased
fluorescent intensity (C and D, respectively) in attempts to identify
microtubule polymerization.
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predominant staining in close proximity to the oolemma
seen in similarly-sized oocytes and follicular stages in
adult mice primed with PMSG. Thus, this intracellular
trafficking of GSK-3 within oocytes is not related to
oocyte size or follicular stage but, more importantly,
related to animal age and/or exogenous hormone stimu-
lation. This would also indicate that this peri-oolemma
location of GSK-3 is not requisite for development
of meiotic competence because no such staining was
found in oocytes from 15-day-old mice when oocytes are
beginning to gain meiotic competence (Schultz and
Wassarman, 1977). This translocation of GSK-3 may
be a component of cytoplasmic oocyte maturation occur-
ring following completion of the oocyte growth phase.
In somatic and neuronal cells LiCl is commonly used
to investigate the role of GSK-3 in cell function
(Stambolic et al., 1996; Lovestone et al., 1999; Manji
et al., 1999; Ohteki et al., 2000). It is important to note
that LiCl, at levels utilized in past (Klein and Melton,
1996; Choi and Sung, 2000) and the current study,
inhibits both GSK-3 and IMPase. While we fully
acknowledge the limitations of this approach we have
attempted to address this specificity issue by inclusion
of the specific IMPase inhibitor, L690,330 (Atack et al.,
1993; Klein and Melton, 1996). While increasing doses
of LiCl had no recognizable influence of oocyte viabi-
lity, development, or morphology; it had striking effects
on microtubule polymerization, spindle formation,
and homologue segregation. This was first visualized
in immunocytochemistry studies where MII oocytes
matured in control media, 20 mM KCl, or 20 mM LiCl
were processed side-by-side in an identical fashion
for identification of spindle formation and chromatin
segregation. Both control-(not shown) and KCl-treated
MII oocytes (Fig. 5, insert) displayed normal micro-
tubule polymerization and homologue separation and
segregation. Using laser intensities determined from
controls andKCl treatment groupswe initially observed
homologue segregation problems and very little signal
for b-tubulin in oocyte matured in the presence of LiCl
(Fig. 5A,B). Increasing laser intensity enabled visuali-
zation of some microtubule polymerization within LiCl-
treated oocytes, yet this polymerization resulted in
abnormal spindle formation. Recall, these oocytes had
undergone cytokinesis and morphologically resembled
MII oocytes. Thus, the question remains: is LiCl com-
promising formation and function of MI, MII, or both
metaphase spindles? While this question remains to be
answered experiments have focused on quantitation of
LiCl-induced homologue separation and segregation
problems and whether this effect is due to GSK-3 or
IMPase inhibition.
In control and KCl-supplemented media incidence of
abnormal homologue segregation was 5%, which is
similar to previously reported values (Sun et al., 2001).
Maturation of oocytes in LiCl induces a significant
increase in homologue segregation problems in compar-
ison to controls. Interestingly, the specific IMPase
inhibitor, L690,330, did not phenocopy the effects of
LiCl onmouse oocyte homologue segregation during the
first meiotic division. This would suggest that aneu-
ploidy problems seen following LiCl-treatment are due
to GSK-3 inhibition and not IMPase inhibition. These
results are similar to those generated in determining
TABLE 3. Survival and In Vitro Maturation of Mouse Oocytes in the Presence of








Control (HTF-H) 93 81 (96) 72 (86) 1 (1)
KCl (20 mM) 84 77 (95) 69 (85) 0 (0)
LiCl (20 mM) 108 106 (99) 98 (92) 0 (0)
L690,330 (20 mM) 108 100 (96) 88 (85) 1 (1)
HTF-H, human tubal fluid with HEPES.
aRates of GVBD, MII development, and activation were calculated based on viable oocytes.
TABLE 2. Survival and In VitroMaturation ofMouseOocytes After 16 hr Exposure









Control (HTF-H) 57 5 (9) 48 (92) 39 (75)
KCl (5 mM) 51 4 (8) 46 (98) 41 (87)
(10 mM) 48 3 (6) 45 (100) 40 (89)
(20 mM) 55 4 (7) 47 (92) 39 (76)
LiCl (5 mM) 45 2 (4) 41 (95) 32 (75)
(10 mM) 49 4 (8) 45 (100) 39 (87)
(20 mM) 64 3 (5) 61 (100) 49 (80)
HTF-H, human tubal fluid with HEPES.
aRates of GVBD and MII development were calculated based on viable oocytes.
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the mechanism by which LiCl induces dorsal–ventral
axis formation aberrations in invertebrate embryogen-
esis (Kao et al., 1986; Klein and Melton, 1996; Rogers
andVarmuza, 1996).HowGSK-3 is involvedwith oocyte
meiotic homologue segregation remains to be deter-
mined. One mechanism may involve GSK-3 regulation
of microtubule-associated protein phosphorylation,
normalmicrotubule polymerization, andnormalmeiotic
spindle formation. GSK-3b has been demonstrated to
have important functional roles in mitotic spindle
orientation in early Caenorhabditis elegans embryos
(Schlesinger et al., 1999) and dorsal–ventral axis
formation in Xenopus (Dominguez et al., 1995) and
zebrafish (Sumoy et al., 1999) embryos. Inneuronal cells
GSK-3 influences microtubule polymerization by reg-
ulating phosphorylation of microtubule-associated
proteins such as tau (Hong et al., 1997; Lovestone
et al., 1999), oncoprotein 18, or stathmin (Moreno and
Avila, 1998), microtubule-associated protein 1 and 2
(Salinas, 1999; Sanchez et al., 2000). GSK-3 inhibition
reduces phosphorylation of microtubule-associated pro-
teins and results in abnormal microtubule polymeriza-
tion. These microtubule-associated proteins have yet to
be identified in mammalian oocytes. Whether this mode
of mediation explains the influence of LiCl-induced
inhibition of GSK-3 and aberrant homologue segrega-
tion is a current areaof investigation.On theotherhand,
GSK-3 may regulate the phosphorylation of chromatid
associated proteins that direct normal homologue
separation and segregation.Recently, cohesin, securins,
Fig. 6. RepresentativeMII oocytes with various categories of homologue segregation patterns. In vitro-
matureMII oocytes in all treatment regimens (control media, 20mMKCl, 20mMLiCl, or 20 mML690,330)
were assessed, blind to treatment, and categorized as having normal (A) or abnormal (B–F) homologue
segregation. Quantitative results are presented in Figure 7.
Fig. 7. Percentage of MII oocytes matured in presence of control
media, KCl, LiCl, or L690,330 with abnormal homologue segregation.
Following 16 hr of in vitro maturation, in various treatment regimens,
morphologically normal MII oocytes were stained with Hoechst 3342
and visualized, blind to treatment, with fluorescent microscopy.
n¼number of MII oocytes assessed in each treatment. Columns with
different letters are significantly different, P< 0.01.
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and separase have been described and implicated in the
regulation of chromatid separation during mitosis
(Uhlmann, 2001), as well as homologue and sister cen-
tromere separation during the first and second meio-
tic divisions, respectively (Buonomo et al., 2000). The
phosphorylated state of cohesin and securins dictate
their integrity and/or activity (Sanchez et al., 1999;
Uhlmannet al., 2000) and thekinases andphosphatases
regulating this reversible phosphorylation remain to be
fully identified. Whether GSK-3 regulates homologue
segregation during the first oocyte meiotic division
through one of these, or through another pathway,
remains to be determined.
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